Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReact Group Regulatory News (REAT)

Share Price Information for React Group (REAT)

Share Price is delayed by 15 minutes
Get Live Data
45.50    0.00 (0.00%)
Bid:
44.00
Ask:
47.00
Spread: 3.00 (6.818%)
Market Cap: £10.75m
REAT Live PriceLast checked at - London Stock Exchange

Intraday React Group Share Chart

Trading Update

21 Oct 2020 07:00

RNS Number : 7091C
React Group PLC
21 October 2020
 

The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

 

 

REACT Group Plc

 

("REACT" or the "Company")

 

Trading update

 

REACT (AIM: REAT.L), the leading specialist cleaning, hygiene and decontamination company, is pleased to announce a trading update for the year ended 30 September 2020.

 

REACT has continued to make strong progress in the period, achieving 42% organic growth in revenue to approximately £4.4m* (12 months ended 30 September 2019: £3.1m).

 

Growth in revenue was as the result of both strong underlying performance in the core business and demand driven by COVID-19 decontaminations. Healthcare, rail, and facilities management sectors performed well, augmented by incremental business in other areas such as education and residential care homes. 

 

The Board expects profit before tax for the year ended 30th September 2020 to be ahead of market expectations driven by both COVID-19 related decontaminations and a number of non-COVID-19 related projects.

 

The Company's financial position is robust and underlying cash generation remained strong during the year ended 30 September 2020. Net cash at 30th September 2020 was also ahead of market expectations at £1.8m*.

 

REACT intends to publish its audited results for the year ended 30th September 2020 towards the end of January 2021.

 

*Figures remain subject to audit

 

Shaun Doak, Chief Executive of REACT, said:

 

"We are pleased to have delivered another year of strong progress in which we saw accelerating organic growth and achievement of the Group's first full year profit.

 

Whilst we have seen a level of disruption from COVID-19, we have also experienced incremental demand. Core sectors of the business performed well alongside net new customer relationships that have evolved in areas of development such as education and residential care homes. This was not true of every sector however, work declined at the height of lockdown in the judiciary where we sanitise and decontaminate courtrooms, cells, and custody vehicles. The sector has since been returning to near normal activity as restrictions have eased.

 

The new financial year has started well with momentum continuing. The immediate outlook is positive, although we are mindful that the seemingly ever-changing environment in which we work can bring with it both opportunities and challenges. As a management team we are reviewing tactics almost daily to ensure REACT remains an effective solution for our customers, our colleagues remain safe, and the business profitable.

 

The last year has presented challenges and opportunities in almost equal measure. On behalf of the Board I wish to express our thanks and appreciation to the terrific team that make up the REACT business. They have responded with focus and commitment throughout, ensuring we continue to deliver services that help our customers return their property to safe operational use." 

 

 

For more information:

 

REACT Group plc

Shaun Doak, Chief Executive Officer

Andrea Pankhurst, Chief Financial Officer

 

 

via Allenby Capital

Tel: +44 (0) 203 328 5656

Allenby Capital Limited

(Nominated Adviser and Broker)

Nick Athanas / Liz Kirchner (Corporate Finance)

Amrit Nahal / Tony Quirke (Sales & Corporate Broking)

 

Tel: +44 (0) 203 328 5656

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAEEEAFEEFAA
Date   Source Headline
17th Jun 202611:56 amRNSDirector/PDMR Shareholding
19th May 202611:23 amRNSInvestor Presentation via Investor Meet Company
19th May 20267:00 amRNSInterim Results and Investor Presentation
13th May 20265:17 pmRNSDirector/PDMR Shareholding
15th Apr 202610:25 amRNSDirector/PDMR Shareholding
31st Mar 20267:28 amRNSAGM Statement
27th Mar 202610:16 amRNSNotice of AGM
13th Feb 20264:22 pmRNSHolding(s) in Company
13th Feb 20264:13 pmRNSHolding(s) in Company
13th Feb 20263:03 pmRNSDirector/PDMR Shareholding
13th Feb 20261:11 pmRNSDirector/PDMR Shareholding
12th Feb 20265:18 pmRNSHolding(s) in Company
12th Feb 202611:35 amRNSHolding(s) in Company
11th Feb 20264:18 pmRNSHolding(s) in Company
10th Feb 20264:33 pmRNSPDMR Dealings
5th Feb 20267:00 amRNSFinal Results
2nd Feb 20267:00 amRNSNotice of Results
19th Jan 20263:37 pmRNSHolding(s) in Company
13th Jan 20262:56 pmRNSDirector/PDMR Shareholding
9th Jan 20263:03 pmRNSHolding(s) in Company
2nd Jan 202611:15 amRNSDirector/PDMR Shareholding
15th Dec 20254:28 pmRNSDirector/PDMR Shareholding
14th Nov 20253:43 pmRNSHolding(s) in Company
28th Oct 20257:00 amRNSTrading Update
16th Oct 20255:18 pmRNSDirector/PDMR Shareholding
16th Sep 20259:13 amRNSDirector/PDMR Shareholding
14th Aug 202511:31 amRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSContract Wins
16th Jul 20252:38 pmRNSShare Incentive Plan
15th Jul 20251:53 pmRNSHolding(s) in Company
27th May 20257:00 amRNSInterim Results & Trading Update
19th May 20258:27 amRNSHolding(s) in Company
29th Apr 202512:30 pmRNSHolding(s) in Company
25th Apr 20252:35 pmRNSHolding(s) in Company
27th Mar 20251:15 pmRNSResult of AGM
27th Mar 20257:00 amRNSAGM Statement
19th Mar 20253:01 pmRNSDirector/PDMR Shareholding
19th Mar 20251:15 pmRNSHolding(s) in Company
6th Mar 202512:09 pmRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSNotice of AGM
12th Feb 20253:34 pmRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNS-RContract Win
30th Jan 20251:59 pmRNSHolding(s) in Company
29th Jan 202511:11 amRNSInvestor Presentation
29th Jan 20257:00 amRNSFinal Results
28th Jan 20256:07 pmRNSHolding(s) in Company
21st Jan 20252:00 pmRNSHolding(s) in Company
8th Nov 20245:12 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSExercise of Options & Total Voting Rights
30th Oct 20243:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.